Advances in care for patients with lymphangioleiomyomatosis (LAM)
Symposium Chairs: V. Cottin (Lyon, France), H. Wirtz (Leipzig, Germany)
Aims: This session will:
- Describe the clinical phenotype and current management of LAM;
- Discuss the monitoring and natural history of the disease;
- Outline the molecular pathology of LAM;
- Describe recent and ongoing clinical trials that represent the current state-of-the-art in the care of patients with this difficult multi-system disorder; and,
- Present the patient's perspective to give insights into the lived experience of the disease and what matters to patients.
Jointly organised by the ERS and LAM Europe, this session will give professionals a comprehensive overview of the multiple presentations of LAM and complications, both pulmonary and systemic. The session will help clinicians to deliver optimal clinical management of this rare and complex disease.